source
- Saudi FDA launches program to accelerate rare-disease drug developmentThe Saudi Food and Drug Authority (SFDA) announced a new initiative called the New Accelerator Program for Drugs in Rare Diseases (NADR). The program is designed to speed up the development, evalu…
- ‘Money has spoken’: Why Chinese biotech CEOs tell Fierce they’re unfazed about rising US tensionsYou might assume Chinese biotechs are enduring sleepless nights worrying about whether the ramping up of rhetoric in the U.S. is putting their new financial gains in peril. But the companies Fierce…Fierce Biotech · 3d ago↗ source